Biotech entity

Metaplanet Inc.

Company 3350.T

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention BeMap, the most common co-covered peer. The tracked stories average 9 original sources each. Metaplanet Inc. appears in 1 tracked Biotech story from February 18, 2026.

Last mentioned: Feb 18, 2026

Entity pulse

Recent coverage · Metaplanet Inc.

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Metaplanet Inc.

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention BeMap, the most common co-covered peer. The tracked stories average 9 original sources each. Metaplanet Inc. appears in 1 tracked Biotech story from February 18, 2026.

Stories tracked
1
Sources per story
9

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Metaplanet Inc.. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Metaplanet Inc. 1

Pharma Strongly positive

Global MedTech and Biotech Stocks Rally Amid Pre-Market Volatility

A global surge in pre-market trading on February 18, 2026, has highlighted significant gains for specialized biotech and MedTech entities. Parx Materials and Coltene Holding led the sector's movement as investors pivoted toward antimicrobial innovation and dental technology amid broader market volatility.

9 sources

Source: Meyka · Meyka

Metaplanet Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.